{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T22:47:08Z","timestamp":1774046828329,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,9]]},"DOI":"10.7759\/cureus.38781","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T18:29:41Z","timestamp":1683656981000},"source":"Crossref","is-referenced-by-count":2,"title":["A Comparative Study of Intralesional Acyclovir vs Immunotherapy for Treatment of Viral Warts"],"prefix":"10.7759","author":[{"given":"E.","family":"Meghana Reddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.S.","family":"Rajashekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Suresh Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04617.x","article-title":"Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial","volume":"146","author":"Al-Gurairi FT","year":"2002","unstructured":"Al-Gurairi FT, Al-Waiz M, Sharquie KE. Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial. Br J Dermatol. 2002, 146:423-31. 10.1046\/j.1365-2133.2002.04617.x","journal-title":"Br J Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2010.01056.x","article-title":"Oral zinc sulfate treatment for viral warts: an open-label study","volume":"38","author":"Mun JH","year":"2011","unstructured":"Mun JH, Kim SH, Jung DS, Ko HC, Kim BS, Kwon KS, Kim MB. Oral zinc sulfate treatment for viral warts: an open-label study. J Dermatol. 2011, 38:541-5. 10.1111\/j.1346-8138.2010.01056.x","journal-title":"J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g3339","article-title":"Management of cutaneous viral warts","volume":"348","author":"Lynch MD","year":"2014","unstructured":"Lynch MD, Cliffe J, Morris-Jones R. Management of cutaneous viral warts. BMJ. 2014, 348:g3339. 10.1136\/bmj.g3339","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13310","article-title":"British Association of Dermatologists' guidelines for the management of cutaneous warts 2014","volume":"171","author":"Sterling JC","year":"2014","unstructured":"Sterling JC, Gibbs S, Haque Hussain SS, Mohd Mustapa MF, Handfield-Jones SE. British Association of Dermatologists' guidelines for the management of cutaneous warts 2014. Br J Dermatol. 2014, 171:696-712. 10.1111\/bjd.13310","journal-title":"Br J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200405050-00004","article-title":"Management of cutaneous warts: an evidence-based approach","volume":"5","author":"Micali G","year":"2004","unstructured":"Micali G, Dall'Oglio F, Nasca MR, Tedeschi A. Management of cutaneous warts: an evidence-based approach. Am J Clin Dermatol. 2004, 5:311-17. 10.2165\/00128071-200405050-00004","journal-title":"Am J Clin Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2165\/11594610-000000000-00000","article-title":"Treatment of cutaneous warts: an evidence-based review","volume":"13","author":"Dall'oglio F","year":"2012","unstructured":"Dall'oglio F, D'Amico V, Nasca MR, Micali G. Treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol. 2012, 13:73-96. 10.2165\/11594610-000000000-00000","journal-title":"Am J Clin Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5070\/D3263048027","article-title":"A review of intralesional wart therapy","volume":"26","author":"Muse ME","year":"2020","unstructured":"Muse ME, Stiff KM, Glines KR, Cline A, Feldman SR. A review of intralesional wart therapy. Dermatol Online J. 2020, 26:2. 10.5070\/D3263048027","journal-title":"Dermatol Online J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/2277-9175.129701","article-title":"Efficacy of intralesional injection of mumps-measles-rubella vaccine in patients with wart","volume":"3","author":"Zamanian A","year":"2014","unstructured":"Zamanian A, Mobasher P, Jazi GA. Efficacy of intralesional injection of mumps-measles-rubella vaccine in patients with wart. Adv Biomed Res. 2014, 3:107. 10.4103\/2277-9175.129701","journal-title":"Adv Biomed Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.79694","article-title":"Intralesional immunotherapy for the management of warts","volume":"77","author":"Chandrashekar L","year":"2011","unstructured":"Chandrashekar L. Intralesional immunotherapy for the management of warts. Indian J Dermatol Venereol Leprol. 2011, 77:261-3. 10.4103\/0378-6323.79694","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.190487","article-title":"Evolving role of immunotherapy in the treatment of refractory warts","volume":"7","author":"Thappa DM","year":"2016","unstructured":"Thappa DM, Chiramel MJ. Evolving role of immunotherapy in the treatment of refractory warts. Indian Dermatol Online J. 2016, 7:364-70. 10.4103\/2229-5178.190487","journal-title":"Indian Dermatol Online J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12230","article-title":"Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study","volume":"28","author":"Shaheen MA","year":"2015","unstructured":"Shaheen MA, Salem SA, Fouad DA, El-Fatah AA. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study. Dermatol Ther. 2015, 28:194-200. 10.1111\/dth.12230","journal-title":"Dermatol Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14839","article-title":"Intralesional immunotherapy with purified protein derivative (PPD) for cryotherapy-resistant warts","volume":"59","author":"Kaimal S","year":"2020","unstructured":"Kaimal S, Gopinath H, Premalatha V. Intralesional immunotherapy with purified protein derivative (PPD) for cryotherapy-resistant warts. Int J Dermatol. 2020, 59:726-9. 10.1111\/ijd.14839","journal-title":"Int J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2012.01477.x","article-title":"Intralesional cidofovir for the treatment of multiple and recalcitrant cutaneous viral warts","volume":"25","author":"Broganelli P","year":"2012","unstructured":"Broganelli P, Chiaretta A, Fragnelli B, Bernengo MG. Intralesional cidofovir for the treatment of multiple and recalcitrant cutaneous viral warts. Dermatol Ther. 2012, 25:468-71. 10.1111\/j.1529-8019.2012.01477.x","journal-title":"Dermatol Ther"},{"key":"ref14","article-title":"Oral acyclovir in the treatment of verruca","volume":"15","author":"Bagwell A","year":"2016","unstructured":"Bagwell A, Loy A, McFarland MS, Tessmer-Neubauer A. Oral acyclovir in the treatment of verruca. J Drugs Dermatol. 2016, 15:237-8.","journal-title":"J Drugs Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90114-0","article-title":"Treatment of plantar warts with acyclovir","volume":"73","author":"Bauer DJ","year":"1982","unstructured":"Bauer DJ. Treatment of plantar warts with acyclovir. Am J Med. 1982, 73:313-14. 10.1016\/0002-9343(82)90114-0","journal-title":"Am J Med"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.3949\/ccjm.50.2.213","article-title":"Does acyclovir have an adjunctive role in plantar wart therapy?","volume":"50","author":"Pechman KJ","year":"1983","unstructured":"Pechman KJ. Does acyclovir have an adjunctive role in plantar wart therapy?. Cleve Clin J Med. 1983, 50:213.","journal-title":"Cleve Clin J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.12.029","article-title":"Treatment of plantar warts with oral valacyclovir","volume":"118","author":"Tandeter H","year":"2005","unstructured":"Tandeter H, Tandeter ER. Treatment of plantar warts with oral valacyclovir. Am J Med. 2005, 118:689-90. 10.1016\/j.amjmed.2004.12.029","journal-title":"Am J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/12034754211037998","article-title":"Intralesional acyclovir: a potential therapeutic option for cutaneous warts","volume":"26","author":"Elsayed A","year":"2022","unstructured":"Elsayed A, Nassar A, Marei A, Hoseiny HA, Alakad R. Intralesional acyclovir: a potential therapeutic option for cutaneous warts. J Cutan Med Surg. 2022, 26:25-30. 10.1177\/12034754211037998","journal-title":"J Cutan Med Surg"},{"key":"ref19","unstructured":"coGuide. (2020). Accessed. April 19, 2023: https:\/\/reap.coguide.in\/."},{"key":"ref20","article-title":"Comparative study of intralesional BCG, and PPD in the treatment of multiple cutaneous warts","volume":"4","author":"Rajashekar TS","year":"2018","unstructured":"Rajashekar TS, Amulya R, Sathish S, Kumar S. Comparative study of intralesional BCG, and PPD in the treatment of multiple cutaneous warts. Indian J Clin Exp Dermatol. 2018, 4:1-6.","journal-title":"Indian J Clin Exp Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000249695","article-title":"A comparison of acyclovir cream versus placebo cream versus liquid nitrogen in the treatment of viral plantar warts","volume":"168","author":"Gibson JR","year":"1984","unstructured":"Gibson JR, Harvey SG, Barth J, Darley CR, Reshad H, Burke CA. A comparison of acyclovir cream versus placebo cream versus liquid nitrogen in the treatment of viral plantar warts. Dermatologica. 1984, 168:178-81. 10.1159\/000249695","journal-title":"Dermatologica"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(82)92618-6","article-title":"Intravenous acyclovir treatment for primary genital herpes","volume":"319","author":"Mindel A","year":"1982","unstructured":"Mindel A, Adler MW, Sutherland S, Fiddian AP. Intravenous acyclovir treatment for primary genital herpes. Lancet. 1982, 319:697-700. 10.1016\/s0140-6736(82)92618-6","journal-title":"Lancet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/sti.59.2.116","article-title":"Topical acyclovir in the treatment of initial genital herpes","volume":"59","author":"Thin RN","year":"1983","unstructured":"Thin RN, Nabarro JM, Parker JD, Fiddian AP. Topical acyclovir in the treatment of initial genital herpes. Br J Vener Dis. 1983, 59:116-19. 10.1136\/sti.59.2.116","journal-title":"Br J Vener Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/153779-a-comparative-study-of-intralesional-acyclovir-vs-immunotherapy-for-treatment-of-viral-warts","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:33Z","timestamp":1707508713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/153779-a-comparative-study-of-intralesional-acyclovir-vs-immunotherapy-for-treatment-of-viral-warts"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.38781","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,9]]}}}